Re: Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection: Reply to the commentary written by Christine Velicer, Alain Luxembourg, Ya-Ting Chen, Melvin Kohn, and Alfred Saah, Merck & Co., Inc., Kenilworth, NJ, USA on the IARC-India HPV vaccine study.

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2025-01-12 Epub Date: 2023-06-14 DOI:10.1016/j.vaccine.2023.06.030

Richard Muwonge, Partha Basu

引用次数: 0

关于利用观察数据探讨当前 HPV 疫苗单剂可提供持久保护的假设：回复美国新泽西州肯尼尔沃思默克公司的 Christine Velicer、Alain Luxembourg、Ya-Ting Chen、Melvin Kohn 和 Alfred Saah 就国际癌症研究机构-印度 HPV 疫苗研究撰写的评论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.